Propanc Biopharma Inc (PPCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 428 | 274 | 383 | 594 | 607 |
| Operating Income | -428 | -274 | -383 | -594 | -607 |
| Interest Expense | 103 | 158 | 159 | 242 | 385 |
| Other Income | 1 | 28 | 117 | 2,041 | -1,620 |
| Pre-tax Income | -530 | -404 | -426 | 1,204 | -2,612 |
| Income Tax | -112 | N/A | N/A | 1 | -26 |
| Net Income Continuous | -418 | -404 | -426 | 1,204 | -2,586 |
| Net Income | $-418 | $-404 | $-426 | $1,204 | $-2,586 |
| EPS Basic Total Ops | -0.12 | -0.45 | -0.71 | 1,408.49 | -348.75 |
| EPS Basic Continuous Ops | -0.12 | -0.45 | -0.71 | 1,408.11 | -348.75 |
| EPS Diluted Total Ops | -0.12 | -0.45 | -0.71 | 1,408.49 | -348.75 |
| EPS Diluted Continuous Ops | -0.12 | -0.45 | -0.71 | 1,408.11 | -348.75 |
| EBITDA(a) | $-427 | $-274 | $-383 | $-594 | $-607 |